Table 1.
Patient Demographics.
| Variable | All (n = 530) Mean ± SD |
Men (n = 266) Mean ± SD |
Women (n = 264) Mean ± SD |
|---|---|---|---|
| Age, years | 68.6 ± 11.2 | 69.8 ± 10.6 | 67.5 ± 11.7 |
| Survival, days | 235 ± 255 | 220 ± 211 | 248 ± 238 |
| ESAS Appetite | 3.5 ± 2.9 | 3.4 ± 2.9 | 3.6 ± 3.0 |
| ESAS QoL | 4.9 ± 2.5 | 4.2 ± 2.4 | 4.2 ± 2.6 |
| ESAS Fatigue | 4.0 ± 2.7 | 4.0 ± 2.7 | 4.0 ± 2.6 |
| ESAS Pain | 2.2 ± 2.3 | 2.1 ± 2.3 | 2.3 ± 2.4 |
| Albumin (g/L) | 30.3 ± 5.2 | 30.1 ± 5.3 | 30.5 ± 5.1 |
| CRP (mg/L) | 29.3 ± 46.4 | 32.7 ± 49.2 | 26.0 ± 43.1 |
| n (%) | n (%) | n (%) | |
| High socioeconomic status | 251 (47.4) | 119 (44.7) | 132 (50.0) |
| Cancer type | |||
| Gastrointestinal | 218 (41.1) | 126 (47.4) | 92 (34.9) |
| Gynecological | 39 (7.4) | 0.00 | 39 (14.8) |
| Head and neck | 11 (2.1) | 9 (3.4) | 2 (0.8) |
| Other | 262 (49.4) | 131 (49.3) | 13 (49.6) |
| Cancer treatment | |||
| Target therapy | 38 (7.2) | 20 (7.5) | 18 (6.8) |
| Chemotherapy | 276 (52.1) | 126 (47.4) | 150 (56.8) |
| No active treatment | 151 (28.79 | 79 (29.7) | 72 (27.7) |
| Hormones | 55 (10.4) | 36 (13.5) | 19 (7.2) |
| Radiotherapy | 9 (1.7) | 5 (1.9) | 4 (1.5) |
ESAS = Edmont Symptom Assessment System. QoL = Quality of Life, CRP = C-reactive protein; High socioeconomic status = living in an area > average Swedish income.